Publications & Works

Published journal articles indexed by SCI, SSCI, and AHCI

Articles Published in Other Journals

Refereed Congress / Symposium Publications in Proceedings

Anti-cancer Effects of Novel Caffeic Acid Phenthyl Ester (CAPE) Analogues on Glioblastome Multiforme Cell Lines

7. Multidisipliner Kanser Araştırma ve 1.Temel Onkoloji Kongresi (MOKAD 2018), İzmir, Turkey, 11 October 2018

Emulsome-based targeted delivery of anti-leishmanial compounds to macrophages

11th European and Global Summit for Clinical Nanomedicine, Targeted Delivery and Precision Medicine – The Building Blocks to Personalized Medicine, Basel, Switzerland, 2 - 05 September 2018, pp.232-234

Novel Drug Discovery Approaches for Cancer with the Inspiration of a Natural Product - Methyl Jasmonate

25th Biennial Congress of the European Association for Cancer Research (EACR25), Amsterdam, Netherlands, 30 June - 03 July 2018 Sustainable Development

Hekzokinaz-2 Enzim İnhibitörü Özgün Metil Jasmonat Analoglarının Sentezi ve İn-Vitro Çalışmaları

Uluslararası Katılımlı 6. İlaç Kimyası: İlaç Etkin Maddesi Tasarımı, Sentezi, Üretimi ve Standardizasyonu Kongresi, Antalya, Turkey, 22 - 25 March 2018

Prostat Kanserini Tedavi Etmek İçin Dosetaksel Konjuge, Prostat Spesifik Membran Antijen Hedefli Aptamer Komplekslerinin Geliştirilmesi

Uluslararası Katılımlı 6. İlaç Kimyası: İlaç Etkin Maddesi Tasarımı, Sentezi, Üretimi ve Standardizasyonu Kongresi, Antalya, Turkey, 22 - 25 March 2018 Sustainable Development

Lipid-Based Emulsome Nanoformulations for Targeted Delivery of Antiparasites

IV Symposium of Tropical Health / COST Action CM 1307 (WG3 and WG4) Joint Meeting, Pamplona, Spain, 4 - 05 May 2017, pp.1-82

Hekzokinaz-2 Enzim İnhibitörü Olarak Kullanılabilecek Anti-Kanser Ajanı Özgün Metil Jasmonat Analoglarının Sentezi ve İn-Vitro Çalışmaları

5. İLAÇ KİMYASI: İLAÇ ETKİN MADDESİ TASARIMI, SENTEZİ, ÜRETİMİ VE STANDARDİZASYONU KONGRESİ, Turkey, 30 March - 02 April 2017 Sustainable Development

Özgün Anti-Kanser İlaç Adayı Keşif ve GeliştirmeÇalışmaları

III. Ulusal Organik Kimya Kongresi, Turkey, 5 - 08 September 2016 Sustainable Development

Synthesis and Biological Evaluation of New A2a Adenosine Receptor Antagonists for the Treatment of Parkinson s Disease

International Multidisciplinary Symposium on Drug Research and Development, 15 - 18 October 2015, vol.1, pp.176

Beyond Warburg Effect Treatment of Cancer as a Metabolic Disease

İnternational BAU Drug Design Congress, İstanbul, Turkey, 1 - 03 October 2015

Novel Targets for Cancer Metabolism

Design of Synthetic Chemical Probes: Tools and Strategies in Medicine &Chemical Biology, İstanbul, Turkey, 13 - 15 September 2015

Novel Drug Candidates for Type 2 Diabetes Mellitus T2DM

Drug Discovery & Therapy World Congress, BOSTON, United States Of America, 22 - 25 July 2015

Novel Metabolic Targets For Cancer Therapy

International 3rd Anticancer Agent Development Congress, İzmir, Turkey, 18 - 19 May 2015

Parkinson Hastalığı Tedavisi İçin Yeni A2A Adenosin Reseptör Antagonistlerinin Sentezi Ve Aktivitelerinin Değerlendirilmesi

3.İlaç Kimyası: İlaç Etkin Maddesi Tasarımı, Sentezi, Üretimi ve Standardizasyonu Kongresi, Turkey, 20 - 22 March 2015

Novel GLP 1R Agonists Road to a Benchmark Drug

National Medicinal Chemistry Congress, Antalya, Turkey, 20 - 22 March 2015

Novel Glucokinase Activators Road to a Benchmark Drug

International Anatolian Conference on Synthetic Organic Chemistry, Antalya, Turkey, 16 - 19 March 2015

Türkiye de İlaç İstismarı Bonzai İle Ölüme Giden Yol Davetli Yazar

Sağlık Düşüncesi ve Tıp Kültürü Dergisi, Turkey, 14 December 2014, pp.58-61

Türkiye de Yenilikçi İlaç İçin Yol Haritası Davetli Yazar

Sağlık Düşüncesi ve Tıp Kültürü Dergisi, Turkey, 15 June 2014, pp.51-57

Glucokinase Activators Road to a Benchmark Drug

International BAU Drug Design Congress, İstanbul, Turkey, 17 - 19 April 2014

Liver Selective Glucokinase Activators A New Treatment Paradigm for Diabetic Patients

Pharmaceutical Developments, BOSTON, United States Of America, 01 November 2009

TTP355 a Liver Selective Glucokinase Activator

American Diabetes Association, New York, United States Of America, 1 - 03 June 2008

Dual Point Binding Enantioselective Catalysts

National Organic Symposium, United States Of America, 13 June 1999

Asymmetric Catalysis via Arene Chromium 0 Carbonyl Complexes

ACS 216th National Meeting, BOSTON, United States Of America, 23 August 1998

Dual Point Binding Enantioselective Lewis Acid Catalysts

National Organic Symposium, United States Of America, 22 June 1997